While long-standing research on IDO has focused on its ability to deplete Trp for immunosuppressive effects, Peter J Murray’s team discovered a new mechanism by which IDO promoted tumor development by transporting the IDO metabolite Kyn into cells via SLC7A11 and inhibiting ferroptosis in the tumor [146]. The gene discussed is SLC7A11; the disease is neoplasm.